Lowenstein represented W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the health care sector, in its acquisition of Symplur, a social media analytics platform exclusively focused on the health care sector.

Symplur provides an easy-to-use interface and analytical capabilities that will help make W2O’s data and analytics operating system and technology accessible to a broader range of nontechnical users. Symplur’s proprietary, purpose-built social media analytics platform–the only tool of its kind on the market designed entirely for health care–allows for the rapid and easy identification of social media trends among physicians, patient advocates, life science professionals, media, and other key audiences of interest to health care organizations, government entities, and academic institutions. Through a collaboration with the California Life Sciences Association, W2O and Symplur are already utilizing the platform in conjunction with W2O’s proprietary data and technology stack to track COVID-19-specific conversations and trends across the health care ecosystem.

The acquisition is designed to expand W2O’s proprietary data and technology platform and corresponding solutions, further enabling the firm to focus on combining data-rich intelligence with technology to solve clients’ problems in real-time, successfully communicate and market their product offerings, and drive overall value for their brands.

Symplur and W2O are privately held companies, and the financial terms of the acquisitions are not being disclosed. This acquisition, which was completed in partnership with W2O’s private equity partner, New Mountain Capital, marks the firm’s fifth acquisition in nine months.

The Lowenstein deal team included David L. Goret, Andrew P. Erdmann, Mary J. Hildebrand, Matt Savare, Michael Walutes, Amy Komoroski Wiwi, Manali Joglekar, Megan Monson, Sophia Mokotoff, Tracy F. Buffer, Danielle Falzone, Bryan Sterba, and Matthew Tippy.